Loading insider details...
Beta
Latest Form 4 (Jun 4, 2026): Grant/Award of 9,000 KLRS shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 4, 2026 | Kalaris Therapeutics, Inc. (KLRS) | Grant/Award | 9,000 | n/a |
| Apr 11, 2025 | Kalaris Therapeutics, Inc. (KLRS) | Grant/Award | 18,000 | n/a |
| Jun 7, 2024 | Allovir, Inc. (ALVR) | Grant/Award | 35,000 | n/a |
| May 12, 2023 | Allovir, Inc. (ALVR) | Grant/Award | 35,000 | n/a |
| Aug 5, 2022 | Cullinan Oncology, Inc. (CGEM) | Sale | 4,792 | $67.6K |
| Aug 1, 2022 | Allovir, Inc. (ALVR) | Grant/Award | 684,622 | $3.16M |
| Jun 29, 2022 | Cullinan Oncology, Inc. (CGEM) | Exercise/Conversion | 104,845 | $450.8K |
| Jun 23, 2022 | Cullinan Oncology, Inc. (CGEM) | Sale | 22,319 | $284.9K |
| May 19, 2022 | Allovir, Inc. (ALVR) | Grant/Award | 27,500 | n/a |
| May 17, 2022 | Cullinan Oncology, Inc. (CGEM) | Sale | 264,072 | $2.44M |